Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ervogastat (PF-06865571) is a potent and well-tolerated diacylglycerol acyltransferase 2 inhibitor. Ervogastat reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 30,500 | |||
5 mg | 在庫あり | ¥ 74,500 | |||
10 mg | 在庫あり | ¥ 124,000 | |||
25 mg | 在庫あり | ¥ 199,500 | |||
50 mg | 在庫あり | ¥ 271,000 | |||
100 mg | 在庫あり | ¥ 365,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 77,000 |
説明 | Ervogastat (PF-06865571) is a potent and well-tolerated diacylglycerol acyltransferase 2 inhibitor. Ervogastat reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH). |
別名 | PF-06865571 |
分子量 | 407.42 |
分子式 | C21H21N5O4 |
CAS No. | 2186700-33-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL(294.54 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ervogastat 2186700-33-2 Metabolism Transferase PF-06865571 PF06865571 PF 06865571 Inhibitor inhibitor inhibit